Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Going to Yellowstone and want to hear the howling of wolves? There are a lot of factors at play but the most important is ...

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune ...

Werewolf Therapeutics Price Performance Shares of NASDAQ:HOWL opened at $0.90 on Thursday. The stock has a market cap of $40.45 million, a PE ratio of -0.59 and a beta of 0.48. The company’s ...

The state wanted no part of the operation, so the Nez Perce stepped in to partner with the federal government.

Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...